Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB AJANTA PHARMA DR. REDDYS LAB/
AJANTA PHARMA
 
P/E (TTM) x 19.8 38.3 51.6% View Chart
P/BV x 4.4 8.3 53.4% View Chart
Dividend Yield % 0.6 0.3 207.4%  

Financials

 DR. REDDYS LAB   AJANTA PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
AJANTA PHARMA
Mar-23
DR. REDDYS LAB/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs4,6561,426 326.6%   
Low Rs3,7881,062 356.6%   
Sales per share (Unadj.) Rs1,481.4297.2 498.4%  
Earnings per share (Unadj.) Rs270.746.7 579.6%  
Cash flow per share (Unadj.) Rs345.757.1 605.6%  
Dividends per share (Unadj.) Rs40.007.00 571.4%  
Avg Dividend yield %0.90.6 168.4%  
Book value per share (Unadj.) Rs1,389.6269.1 516.5%  
Shares outstanding (eoy) m166.53125.91 132.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.84.2 68.1%   
Avg P/E ratio x15.626.6 58.6%  
P/CF ratio (eoy) x12.221.8 56.0%  
Price / Book Value ratio x3.04.6 65.7%  
Dividend payout %14.815.0 98.6%   
Avg Mkt Cap Rs m703,039156,638 448.8%   
No. of employees `000NANA-   
Total wages/salary Rs m46,4667,851 591.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m246,69737,426 659.2%  
Other income Rs m10,555986 1,070.1%   
Total revenues Rs m257,25238,413 669.7%   
Gross profit Rs m63,8607,833 815.3%  
Depreciation Rs m12,5021,308 955.8%   
Interest Rs m1,42858 2,445.2%   
Profit before tax Rs m60,4857,453 811.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,4121,573 980.0%   
Profit after tax Rs m45,0735,880 766.6%  
Gross profit margin %25.920.9 123.7%  
Effective tax rate %25.521.1 120.7%   
Net profit margin %18.315.7 116.3%  
BALANCE SHEET DATA
Current assets Rs m203,16128,252 719.1%   
Current liabilities Rs m85,72111,393 752.4%   
Net working cap to sales %47.645.0 105.7%  
Current ratio x2.42.5 95.6%  
Inventory Days Days7966 120.4%  
Debtors Days Days10710 1,040.5%  
Net fixed assets Rs m112,63818,707 602.1%   
Share capital Rs m833253 329.6%   
"Free" reserves Rs m230,57133,624 685.7%   
Net worth Rs m231,40433,877 683.1%   
Long term debt Rs m1,27813 10,224.0%   
Total assets Rs m315,79947,047 671.2%  
Interest coverage x43.4128.6 33.7%   
Debt to equity ratio x00 1,496.7%  
Sales to assets ratio x0.80.8 98.2%   
Return on assets %14.712.6 116.7%  
Return on equity %19.517.4 112.2%  
Return on capital %26.622.2 120.1%  
Exports to sales %52.259.9 87.2%   
Imports to sales %16.811.5 146.6%   
Exports (fob) Rs m128,80322,420 574.5%   
Imports (cif) Rs m41,4844,293 966.3%   
Fx inflow Rs m128,80322,420 574.5%   
Fx outflow Rs m41,4844,293 966.3%   
Net fx Rs m87,31918,127 481.7%   
CASH FLOW
From Operations Rs m58,8757,918 743.6%  
From Investments Rs m-41,373-5,596 739.3%  
From Financial Activity Rs m-26,861-1,079 2,490.1%  
Net Cashflow Rs m-9,0731,243 -729.9%  

Share Holding

Indian Promoters % 26.7 66.2 40.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 47.3 25.8 183.4%  
FIIs % 28.6 9.1 314.2%  
ADR/GDR % 15.3 0.0 -  
Free float % 58.0 33.8 171.7%  
Shareholders   257,794 54,351 474.3%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Dr. Reddys vs AJANTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs AJANTA PHARMA Share Price Performance

Period Dr. Reddys AJANTA PHARMA S&P BSE HEALTHCARE
1-Day 2.05% 2.60% 1.18%
1-Month -3.97% 7.69% -0.75%
1-Year 36.30% 93.08% 61.82%
3-Year CAGR 10.95% 21.67% 18.16%
5-Year CAGR 17.83% 26.87% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the AJANTA PHARMA share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of AJANTA PHARMA the stake stands at 66.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of AJANTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 14.8%.

AJANTA PHARMA paid Rs 7.0, and its dividend payout ratio stood at 15.0%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of AJANTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.